Screener
Praxis Precision Medicines, Inc. PRAX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s total liabilities?
- Praxis Precision Medicines, Inc. (PRAX) reported total liabilities of $49.06M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s total liabilities changed year-over-year?
- Praxis Precision Medicines, Inc.'s total liabilities increased by 0.9% year-over-year, from $48.61M to $49.06M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total liabilities has grown at a 30.6% compound annual growth rate (CAGR), from $15.72M to $59.77M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Praxis Precision Medicines, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude